MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Simple Search Results

Didn't find what you were looking for? Try the Advanced Search »

  • 1
  • 2
  • 3
  • …
  • 13
  • Next Page »
Search Again »
  • 2024 International Congress

    Safety and effectiveness of staged bilateral MR-guided focused ultrasound pallidothalamic tractotomy for motor complications of Parkinson’s disease: study protocol

    A. Dalvi, L. Zucker, WC. Chang, PH. Wu, M. Kaplitt, H. Sarva, HM. Eisenberg, P. Fishman, V. Buch, M. Matarazzo, M. Del Alamo, S. Sani, M. Pourfar, A. Mogilner (West Palm Beach, USA)

    Objective: To describe the protocol of a study evaluating the safety and effectiveness of magnetic resonance-guided focused ultrasound (MRgFUS) pallidothalamic tractotomy (PTT) as a staged…
  • 2024 International Congress

    Focused Ultrasound Therapy Treatment for Parkinson’s Disease

    Z. Muttalib, B. Syed, M. Alam, D. Nadora, U. Ansari, R. Sedighi, A. Vemulapalli, S. Asad (Elk Grove, USA)

    Objective: Parkinson’s Disease is a neurodegenerative disease that mainly affects the substantia nigra and nigrostriatal pathway and leads to rigidity, loss of muscle tone, tremors,…
  • 2024 International Congress

    Focused ultrasound subthalamotomy in early Parkinson´s disease: three-year prospective follow-up

    E. Natera-Villalba, R. Martínez-Fernández, R. Rodríguez-Rojas, M. Del álamo, JA. Pineda-Pardo, I. Obeso, M. Escribano, T. Jiménez Castellanos, C. Gasca-Salas, M. Matarazzo, JA. Obeso (Madrid, Spain)

    Objective: To assess the safety and efficacy of focused ultrasound subthalamotomy (FUS-STN) for Parkinson´s disease (PD) in patients who received the procedure within the first…
  • 2024 International Congress

    Behavioral health characteristics of pre-surgical Focused Ultrasound and Deep Brain Stimulation candidates

    D. Kim, S. O'Neill, S. Murthy, A. Waters, C. Palmese (Bronx, USA)

    Objective: To characterize psychological traits in patients who pursue focused ultrasound (FUS) versus deep brain stimulation (DBS) for tremor management Background: Psychosocial characteristics can determine…
  • 2024 International Congress

    Focused Ultrasound Thalamotomy for Tremor-Dominant Parkinson Disease – Ablation Volume and Dentatorubrothalamic Tract Overlap Does Not Predict Outcome

    J. Peters, J. Maamary, K. Kyle, I. Osborne, N. Olsen, L. Jones, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)

    Objective: To report the long-term outcomes in Tremor-Dominant Parkinson Disease (TDPD) after a unilateral Focused Ultrasound (uni-FUS) thalamotomy and explore factors that may predict the…
  • 2024 International Congress

    A comparative study of focused ultrasound unilateral thalamotomy and subthalamotomy for medication refractory Parkinsonian tremor

    S. Paschen, E. Natera, J. Pineda-Pardo, M. Del Alamo, R. Rodríguez-Rojas, G. Deuschl, J. Obeso, AK. Helmers, R. Martínez Fernández (Kiel, Germany)

    Objective: Unilateral focused ultrasound (FUS) thalamotomy of the ventral intermediate thalamic nucleus (FUS-Vim) is effective in treating Parkinson’s disease (PD) tremor. FUS ablation of the…
  • 2024 International Congress

    Impact on quality of life and nonmotor symptoms of unilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy in patients with essential tremor.

    D. Vilas, L. Ispierto, M. Tardáguila, J. Muñoz, A. González, M. Gea, JA. Pérez, R. García-Yuste, R. álvarez (Badalona, Spain)

    Objective: To describe the impact on quality of life (QoL) and nonmotor symptoms of unilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy in patients with refractory…
  • 2024 International Congress

    Safety and efficacy of bilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy for refractory essential tremor.

    D. Vilas, L. Ispierto, M. Tardáguila, J. Muñoz, A. González, JA. Pérez, R. García, R. álvarez (Badalona, Spain)

    Objective: To describe the safety and efficacy of bilateral focused ultrasound thalamotomy (FUS) in a cohort of patients with essential tremor (ET) within the Spanish…
  • 2024 International Congress

    Extended long-term follow-up focused ultrasound subthalamotomy in Parkinson´s disease: five-year prospective experience

    E. Natera-Villalba, T. Jiménez Castellanos, R. Rodríguez-Rojas, M. Del álamo, JA. Pineda-Pardo, C. Gasca-Salas, M. Matarazzo, JA. Obeso, R. Martínez-Fernández (Madrid, Spain)

    Objective: To assess the safety and efficacy of unilateral focused ultrasound subthalamotomy (FUS-STN) for Parkinson`s disease (PD) 5 years after treatment. Background: FUS-STN improves cardinal…
  • 2024 International Congress

    Safety of staged bilateral MR-guided focused ultrasound thalamotomy for essential tremor

    M. Kaplitt, H. Sarva, V. Krishna, HM. Eisenberg, WJ. Elias, P. Ghanouni, GH. Baltuch, A. Rezai, C. Halpern, B. Dalm, P. Fishman, V. Buch, S. Moosa, AM. Murray (New York, USA)

    Objective: To evaluate the efficacy and safety of staged bilateral magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy in patients with medication-refractory bilateral essential tremor (ET). Herein,…
  • 1
  • 2
  • 3
  • …
  • 13
  • Next Page »
Search Again »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley